Introduction

Characteristics

Fate and Transport

Exposure Pathway

Methods for Monitoring in the Environment

Methods for Measuring Human Exposure

Strategies for Preventing or Controlling Exposure

Respiratory Harmful Effects

Deposition, Absorption, and Metabolism

Dose-Response Relationship

Organ Sites of Toxicity

Biomarkers

Risk Assessment/Risk Management Considerations

References

Return to 5103/5104 Home

ETS is a lung irritant, particularly for a child with asthma. Recall:
o children breathe more air than adults, and have narrower airways
o asthma is characterized by inflammation of the lungs


ETS is transported via air, and inhaled into the lungs by nonsmokers

Hypertrophy and hyperplasia of the upper airway mucous glands leads to an increase in mucous production, associated with increased cough and phlegm


Chronic inflammation of the smaller airways occurs, on top of the already inflamed respiratory system of an individual with asthma


Acrolein and acetone are known to affect mucocilliary function, which leads to inhibition of the ability to clear smoke particles from lung